This inventor holds 63 USPTO granted patents and 20 published patent applications, plus 10 CIPO patents and 19 EPO patents, primarily in Histone Deacetylase Inhibitors (CPC class C07D). Top assignees: Harvard College, The General Hospital Corporation, Acetylon Pharmaceuticals, Inc.. Active years: 2012-2026.
Inventors with similar research interests:
Location History:
- Arlington, MA (US) (2012 - 2019)
- Belmont, MA (US) (2012 - 2024)
- Weston, MA (US) (2020 - 2024)
Company Filing History:
18 out of 3,069 
18 out of 3,068 
16 out of 35 
Years Active: 2012-2026
Areas of Expertise:
Title: The Innovative Mind of Ralph Mazitschek
Introduction: Ralph Mazitschek, a brilliant inventor hailing from Belmont, MA, has made significant contributions to the field of science and technology through his groundbreaking innovations.
Latest Patents: Ralph Mazitschek holds several patents in the areas of biotechnology and pharmaceuticals, with his most recent patent focusing on a novel drug delivery system that has the potential to revolutionize the way medications are administered.
Career Highlights: With a background in biochemistry and pharmacology, Ralph Mazitschek has dedicated his career to developing cutting-edge solutions to complex medical challenges. His work has been recognized for its ingenuity and impact on the healthcare industry.
Collaborations: Throughout his career, Ralph Mazitschek has collaborated with leading researchers, scientists, and pharmaceutical companies to further advance his inventions. His collaborative spirit and innovative approach have led to the successful development of several groundbreaking technologies.
Conclusion: Ralph Mazitschek's passion for innovation and his relentless pursuit of scientific excellence have solidified his reputation as a pioneering inventor in the field of biotechnology. His contributions continue to inspire future generations of inventors and researchers to push the boundaries of what is possible in the world of science and technology.